Latest On Xtant Medical Holdings, Inc (XTNT):
About Xtant Medical Holdings, Inc (XTNT):
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS DBM Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; and OsteoWrap that wraps around non-union fractures to assist with fusion, as well as used in conjunction with a hardware plate system. The company also provides 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers Certex spinal fixation system; Spider cervical plating system; Axle Interspinous Fusion System; Silex Sacroiliac joint fusion system; Xpress minimally invasive pedicle screw system; and Fortex Pedicle screw system. Additionally, it provides Calix for cervical and thoracolumbar applications, Axle-X interspinous fusion system, Irix-C cervical integrated fusion system, and Irix-A Lumbar integrated fusion system. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.
General
- Name Xtant Medical Holdings, Inc
- Symbol XTNT
- Type Common Stock
- Exchange NYSE MKT
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Devices
- Full Time Employees 110
- Last Split Factor1:12
- Last Split Date2018-02-14
- Fiscal Year EndDecember
- IPO Date2015-10-19
- Gic SectorHealth Care
- Gic GroupHealth Care Equipment & Services
- Gic IndustryHealth Care Equipment & Supplies
- Gic SubIndustryHealth Care Supplies
- Web URLhttp://www.xtantmedical.com
Valuation
- Price/Sales (Trailing 12 Mt.) 2.06
- Price/Book (Most Recent Quarter) 23.06
- Enterprise Value Revenue 6.58
- Enterprise Value EBITDA 264.23
Financials
- Most Recent Quarter 2020-12-31
- Profit Margin -13%
- Operating Margin 2%
- Return on Assets 1%
- Revenue 53.34 million
- Earnings Per Share -$4.90
- Revenue Per Share $1.87
- Gross Profit 34.39 million
- Quarterly Earnings Growth -17.4%
Highlights
- Market Capitalization 247.98 million
- EBITDA 2.93 million
- PEG Ratio -0.03
- Analyst Target Price $1
- Book Value Per Share $0.19
Share Statistics
- Shares Outstanding 86.71 million
- Shares Float 4.38 million
- % Held by Insiders 234%
- % Held by Institutions 95.88%
- Shares Short 16376
- Shares Short Prior Month 197613
Technicals
- Beta 1.62
- 52 Week High $4.9
- 52 Week Low $0.56
- 50 Day Moving Average 2.35
- 200 Day Moving Average 1.5
Dividends
- Dividend Date 2018-02-14
- ExDividend Date N/A
- Dividend Yield 0%
Xtant Medical Holdings, Inc (XTNT) Dividend Calendar:
XTNT's last dividend payment was made to shareholders on February 14, 2018.
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Xtant Medical Holdings, Inc (XTNT) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-12-31 | 2021-02-24 | $14.02 million | -$0.01 | ||
2020-09-30 | 2020-10-29 | $N/A | -$0.10 | -$0.11 | 9.09% |
2020-06-30 | 2020-08-03 | $N/A | -$0.19 | -$0.11 | -72.73% |
2020-03-31 | 2020-05-07 | $14.78 million | -$0.10 | ||
2019-12-31 | 2020-03-05 | $16.96 million | -$0.12 | -$0.21 | 42.86% |
2019-09-30 | 2019-11-07 | $15.72 million | -$0.14 | -$0.28 | 50% |
2019-06-30 | 2019-08-08 | $15.27 million | -$0.15 | -$0.52 | 71.15% |
2019-03-31 | 2019-05-15 | $16.73 million | -$0.21 | -$0.36 | 41.67% |
2018-12-31 | 2018-12-31 | $18.26 million | -$0.23 | -$0.32 | 28.13% |
2018-09-30 | 2018-11-14 | $17.27 million | -$0.24 | -$0.19 | -26.32% |
2018-06-30 | 2018-08-07 | $18.74 million | -$0.38 | -$0.27 | -40.74% |
2018-03-31 | 2018-05-08 | $17.93 million | -$0.70 | -$0.75 | 6.67% |
2017-12-31 | 2018-03-13 | $19.33 million | -$18.77 | -$3.49 | -437.68% |
2017-09-30 | 2017-11-21 | $19.79 million | -$5.64 | -$3.12 | -80.78% |
2017-06-30 | 2017-08-09 | $21.41 million | -$6.48 | -$2.88 | -125% |
2017-03-31 | 2017-05-09 | $22.08 million | -$3.48 | -$3.60 | 3.33% |
2016-12-31 | 2017-03-09 | $24.47 million | -$3.72 | -$3.12 | -19.23% |
2016-09-30 | 2016-11-07 | $23.09 million | -$4.80 | -$3.72 | -29.03% |
2016-06-30 | 2016-08-01 | $21.46 million | -$4.44 | -$5.16 | 13.95% |
2016-03-31 | 2016-05-04 | $20.98 million | -$5.64 | -$5.04 | -11.9% |
2015-12-31 | 2016-03-15 | $22.27 million | $11.64 | -$5.88 | 297.96% |
2015-09-30 | 2015-11-11 | $17.68 million | -$0.47 | -$0.18 | -161.11% |
2015-06-30 | 2015-08-12 | $9.89 million | -$0.41 | -$0.34 | -20.59% |
2015-03-31 | 2015-05-05 | $9.5 million | -$0.62 | -$0.35 | -77.14% |
2014-12-31 | 2015-03-17 | $9.08 million | -$0.46 | -$0.35 | -31.43% |
2014-09-30 | 2014-11-05 | $8.45 million | -$0.46 | -$0.23 | -100% |
2014-06-30 | 2014-08-12 | $8.88 million | -$4.20 | -$5.58 | 24.73% |
2014-03-31 | 2014-05-06 | $8.91 million | -$9.60 | -$4.80 | -100% |
2013-12-31 | 2014-03-19 | $8.26 million | -$8.40 | -$8.80 | 4.55% |
2013-09-30 | 2013-11-07 | $7.93 million | -$9.60 | -$5.70 | -68.42% |
2013-06-30 | 2013-08-06 | $8.27 million | -$4.80 | -$4.40 | -9.09% |
2013-03-31 | 2013-05-09 | $8.62 million | -$4.80 | -$5.60 | 14.29% |
2012-12-31 | 2013-03-26 | $8.12 million | -$13.20 | -$4.08 | -223.53% |
2012-09-30 | 2012-11-07 | $8.88 million | -$7.20 | -$4.56 | -57.89% |
2012-06-30 | 2012-08-09 | $8.21 million | $2.40 | -$5.28 | 145.45% |
2012-03-31 | 2012-05-03 | $7.77 million | -$3.60 | -$4.80 | 25% |
2011-12-31 | 2012-03-22 | $9.1 million | -$13.20 | -$4.08 | -223.53% |
2011-09-30 | 2011-11-10 | $7.54 million | -$9.60 | -$1.20 | -700% |
2011-06-30 | 2011-08-11 | $7.51 million | -$1.20 | -$7.20 | 83.33% |
2011-03-31 | 2011-06-01 | $6 million | $13.28 | ||
2010-12-31 | 2011-03-02 | $5.29 million | -$18.10 | ||
2010-09-30 | 2010-09-30 | $4.19 million | -$30.66 |
Xtant Medical Holdings, Inc (XTNT) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
Xtant Medical Holdings, Inc (XTNT) Chart:
Xtant Medical Holdings, Inc (XTNT) News:
Below you will find a list of latest news for Xtant Medical Holdings, Inc (XTNT) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Xtant Medical Holdings, Inc (XTNT) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|
Latest XTNT Trades:
Date | Shares | Price |
---|---|---|
Jun 13, 2022 5:52 PM EST | 100 | $0.5234 |
Jun 13, 2022 6:45 PM EST | 1 | $0.52 |
Jun 13, 2022 7:02 PM EST | 1 | $0.518 |
Jun 13, 2022 7:12 PM EST | 1 | $0.5245 |
Jun 13, 2022 7:21 PM EST | 1 | $0.5222 |
Xtant Medical Holdings, Inc (XTNT) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580220000048/0001235802-20-000048-index.htm |
2018-05-23 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1453593/000000000018015998/0000000000-18-015998-index.htm |
2019-02-15 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1453593/000088430019000006/0000884300-19-000006-index.htm |
2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1453593/000090571819000209/0000905718-19-000209-index.htm |
2018-09-19 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1453593/000094787118000751/0000947871-18-000751-index.htm |
2018-09-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000094787118000752/0000947871-18-000752-index.htm |
2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000094787119000265/0000947871-19-000265-index.htm |
2019-04-04 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1453593/000094787119000268/0000947871-19-000268-index.htm |
2020-05-20 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1453593/000094787120000504/0000947871-20-000504-index.htm |
2020-10-05 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1453593/000094787120000774/0000947871-20-000774-index.htm |
2018-04-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1453593/000114420418021015/0001144204-18-021015-index.htm |
2018-04-25 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1453593/000114420418022350/0001144204-18-022350-index.htm |
2018-04-27 | 424B1 | Prospectus [Rule 424(b)(1)] | https://www.sec.gov/Archives/edgar/data/1453593/000114420418023189/0001144204-18-023189-index.htm |
2018-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000114420418025318/0001144204-18-025318-index.htm |
2018-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1453593/000114420418026164/0001144204-18-026164-index.htm |
2018-05-15 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1453593/000114420418028900/0001144204-18-028900-index.htm |
2018-05-16 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1453593/000114420418029220/0001144204-18-029220-index.htm |
2018-05-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1453593/000114420418029837/0001144204-18-029837-index.htm |
2018-05-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1453593/000114420418029946/0001144204-18-029946-index.htm |
2018-05-30 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1453593/000114420418031665/0001144204-18-031665-index.htm |
2018-05-30 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1453593/000114420418031675/0001144204-18-031675-index.htm |
2018-06-01 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1453593/000114420418032157/0001144204-18-032157-index.htm |
2018-06-04 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1453593/000114420418032695/0001144204-18-032695-index.htm |
2018-07-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580218000092/0001235802-18-000092-index.htm |
2018-08-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580218000122/0001235802-18-000122-index.htm |
2018-08-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580218000123/0001235802-18-000123-index.htm |
2018-08-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580218000124/0001235802-18-000124-index.htm |
2018-08-22 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580218000137/0001235802-18-000137-index.htm |
2018-09-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580218000144/0001235802-18-000144-index.htm |
2018-09-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580218000146/0001235802-18-000146-index.htm |
2018-09-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580218000147/0001235802-18-000147-index.htm |
2018-10-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580218000155/0001235802-18-000155-index.htm |
2019-01-11 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580219000007/0001235802-19-000007-index.htm |
2019-01-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580219000008/0001235802-19-000008-index.htm |
2019-02-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580219000013/0001235802-19-000013-index.htm |
2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580219000036/0001235802-19-000036-index.htm |
2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580219000037/0001235802-19-000037-index.htm |
2019-08-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580219000103/0001235802-19-000103-index.htm |
2019-08-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580219000104/0001235802-19-000104-index.htm |
2019-09-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580219000121/0001235802-19-000121-index.htm |
2019-09-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580219000122/0001235802-19-000122-index.htm |
2019-09-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580219000123/0001235802-19-000123-index.htm |
2019-10-15 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580219000128/0001235802-19-000128-index.htm |
2019-10-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580219000129/0001235802-19-000129-index.htm |
2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580220000003/0001235802-20-000003-index.htm |
2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580220000004/0001235802-20-000004-index.htm |
2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580220000005/0001235802-20-000005-index.htm |
2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580220000006/0001235802-20-000006-index.htm |
2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580220000007/0001235802-20-000007-index.htm |
2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580220000008/0001235802-20-000008-index.htm |
2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580220000046/0001235802-20-000046-index.htm |
2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580220000047/0001235802-20-000047-index.htm |
2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580220000048/0001235802-20-000048-index.htm |
2020-08-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580220000097/0001235802-20-000097-index.htm |
2020-08-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580220000098/0001235802-20-000098-index.htm |
2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580220000117/0001235802-20-000117-index.htm |
2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580220000118/0001235802-20-000118-index.htm |
2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580220000119/0001235802-20-000119-index.htm |
2020-10-05 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1453593/000123580220000120/0001235802-20-000120-index.htm |
2018-06-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1453593/000149315218008885/0001493152-18-008885-index.htm |
2018-06-26 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1453593/000149315218009197/0001493152-18-009197-index.htm |
2018-06-26 | DEFR14A | Revised definitive proxy soliciting materials | https://www.sec.gov/Archives/edgar/data/1453593/000149315218009212/0001493152-18-009212-index.htm |
2018-07-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1453593/000149315218009846/0001493152-18-009846-index.htm |
2018-08-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1453593/000149315218010957/0001493152-18-010957-index.htm |
2018-08-03 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1453593/000149315218010959/0001493152-18-010959-index.htm |
2018-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1453593/000149315218011100/0001493152-18-011100-index.htm |
2018-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1453593/000149315218011170/0001493152-18-011170-index.htm |
2018-08-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1453593/000149315218012342/0001493152-18-012342-index.htm |
2018-09-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1453593/000149315218013320/0001493152-18-013320-index.htm |
2018-10-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1453593/000149315218014218/0001493152-18-014218-index.htm |
2018-10-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1453593/000149315218014461/0001493152-18-014461-index.htm |
2018-11-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1453593/000149315218016066/0001493152-18-016066-index.htm |
2018-11-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1453593/000149315218016195/0001493152-18-016195-index.htm |
2019-02-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1453593/000149315219001699/0001493152-19-001699-index.htm |
2019-03-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1453593/000149315219003636/0001493152-19-003636-index.htm |
2019-04-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1453593/000149315219004394/0001493152-19-004394-index.htm |
2019-04-01 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1453593/000149315219004396/0001493152-19-004396-index.htm |
2019-04-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1453593/000149315219004980/0001493152-19-004980-index.htm |
2019-04-29 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1453593/000149315219006070/0001493152-19-006070-index.htm |
2019-05-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1453593/000149315219007213/0001493152-19-007213-index.htm |
2019-05-15 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1453593/000149315219007404/0001493152-19-007404-index.htm |
2019-05-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1453593/000149315219008280/0001493152-19-008280-index.htm |
2019-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1453593/000149315219011840/0001493152-19-011840-index.htm |
2019-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1453593/000149315219011846/0001493152-19-011846-index.htm |
2019-08-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1453593/000149315219013115/0001493152-19-013115-index.htm |
2019-09-05 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1453593/000149315219013733/0001493152-19-013733-index.htm |
2019-09-20 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1453593/000149315219014334/0001493152-19-014334-index.htm |
2019-10-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1453593/000149315219015114/0001493152-19-015114-index.htm |
2019-10-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1453593/000149315219016278/0001493152-19-016278-index.htm |
2019-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1453593/000149315219016582/0001493152-19-016582-index.htm |
2019-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1453593/000149315219016584/0001493152-19-016584-index.htm |
2019-11-08 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1453593/000149315219016707/0001493152-19-016707-index.htm |
2020-03-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1453593/000149315220003409/0001493152-20-003409-index.htm |
2020-03-05 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1453593/000149315220003410/0001493152-20-003410-index.htm |
2020-03-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1453593/000149315220004669/0001493152-20-004669-index.htm |
2020-04-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1453593/000149315220006207/0001493152-20-006207-index.htm |
2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1453593/000149315220007867/0001493152-20-007867-index.htm |
2020-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1453593/000149315220007869/0001493152-20-007869-index.htm |
2020-08-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1453593/000149315220014472/0001493152-20-014472-index.htm |
2020-08-03 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1453593/000149315220014475/0001493152-20-014475-index.htm |
2020-08-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1453593/000149315220015035/0001493152-20-015035-index.htm |
2020-08-12 | PRE 14C | Other preliminary information statements | https://www.sec.gov/Archives/edgar/data/1453593/000149315220015294/0001493152-20-015294-index.htm |
2020-09-10 | DEF 14C | Other definitive information statements | https://www.sec.gov/Archives/edgar/data/1453593/000149315220017510/0001493152-20-017510-index.htm |
2020-09-10 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1453593/000149315220017513/0001493152-20-017513-index.htm |
2020-09-11 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1453593/000149315220017658/0001493152-20-017658-index.htm |
2020-10-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1453593/000149315220018693/0001493152-20-018693-index.htm |
2020-10-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1453593/000149315220018971/0001493152-20-018971-index.htm |
2020-10-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1453593/000149315220019819/0001493152-20-019819-index.htm |
2020-10-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1453593/000149315220020040/0001493152-20-020040-index.htm |
2020-10-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1453593/000149315220020088/0001493152-20-020088-index.htm |
2020-10-29 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1453593/000149315220020089/0001493152-20-020089-index.htm |
2020-10-30 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1453593/000149315220020236/0001493152-20-020236-index.htm |
2020-10-30 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1453593/000149315220020239/0001493152-20-020239-index.htm |
2020-11-05 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1453593/000149315220020535/0001493152-20-020535-index.htm |
2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1453593/000153705519000003/0001537055-19-000003-index.htm |
2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1453593/000153705520000003/0001537055-20-000003-index.htm |
2019-10-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000179030019000005/0001790300-19-000005-index.htm |
2019-10-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000179030019000006/0001790300-19-000006-index.htm |
2019-10-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1453593/000179030019000007/0001790300-19-000007-index.htm |
2018-04-27 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1453593/999999999518000955/9999999995-18-000955-index.htm |
2018-06-04 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1453593/999999999518001404/9999999995-18-001404-index.htm |
2020-11-03 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1453593/999999999520003071/9999999995-20-003071-index.htm |
Xtant Medical Holdings, Inc (XTNT) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Xtant Medical Holdings, Inc (XTNT). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 234%Institutional Ownership: 9588%
Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
---|---|---|---|---|---|---|---|---|
2020-08-15 | GREG JENSEN | VP, Finance and CFO | Buy | 95,183.00 | 129,081.00 | https://www.sec.gov/Archives/edgar/data/1453593/000123580220000098/0001235802-20-000098-index.htm | ||
2020-02-05 | Robert McNamara | Director | Buy | 116,197.00 | 146,057.00 | https://www.sec.gov/Archives/edgar/data/1453593/000123580220000004/0001235802-20-000004-index.htm | ||
2020-02-05 | Jeffrey J Peters | Director | Buy | 116,197.00 | 147,794.00 | https://www.sec.gov/Archives/edgar/data/1453593/000123580220000005/0001235802-20-000005-index.htm | ||
2020-02-05 | JOHN K BAKEWELL | Director | Buy | 116,197.00 | 147,794.00 | https://www.sec.gov/Archives/edgar/data/1453593/000123580220000003/0001235802-20-000003-index.htm | ||
2020-10-01 | Matthew Rizzo | Director | Buy | 11,969,619.00 | 1.07 | 12,807,492.33 | 15,300,688.00 | https://www.sec.gov/Archives/edgar/data/1453593/000123580220000118/0001235802-20-000118-index.htm |
2020-10-01 | Michael Eggenberg | Director | Buy | 11,969,619.00 | 1.07 | 12,807,492.33 | 15,300,688.00 | https://www.sec.gov/Archives/edgar/data/1453593/000123580220000119/0001235802-20-000119-index.htm |
2020-10-01 | ORBIMED ADVISORS LLC | Director | Buy | 11,969,619.00 | 1.07 | 12,807,492.33 | 15,300,688.00 | https://www.sec.gov/Archives/edgar/data/1453593/000123580220000117/0001235802-20-000117-index.htm |
2020-08-15 | Kevin D Brandt | Chief Commercial Officer | Buy | 95,183.00 | 170,352.00 | https://www.sec.gov/Archives/edgar/data/1453593/000123580220000097/0001235802-20-000097-index.htm | ||
2019-10-30 | Matthew Rizzo | Director | Buy | 20,833.00 | 20,833.00 | https://www.sec.gov/Archives/edgar/data/1453593/000179030019000007/0001790300-19-000007-index.htm | ||
2019-10-30 | Michael Eggenberg | Director | Buy | 20,833.00 | 20,833.00 | https://www.sec.gov/Archives/edgar/data/1453593/000179030019000005/0001790300-19-000005-index.htm | ||
2018-05-02 | Robert McNamara | Director | Buy | 20,833.00 | 20,833.00 | https://www.sec.gov/Archives/edgar/data/1453593/000114420418025318/0001144204-18-025318-index.htm | ||
2018-08-15 | Jeffrey J Peters | Director | Buy | 26,042.00 | 26,042.00 | https://www.sec.gov/Archives/edgar/data/1453593/000123580218000124/0001235802-18-000124-index.htm | ||
2019-09-24 | Robert McNamara | Director | Buy | 9,027.00 | 29,860.00 | https://www.sec.gov/Archives/edgar/data/1453593/000123580219000123/0001235802-19-000123-index.htm | ||
2019-09-24 | Jeffrey J Peters | Director | Buy | 5,555.00 | 31,597.00 | https://www.sec.gov/Archives/edgar/data/1453593/000123580219000121/0001235802-19-000121-index.htm | ||
2019-09-24 | JOHN K BAKEWELL | Director | Buy | 5,555.00 | 31,597.00 | https://www.sec.gov/Archives/edgar/data/1453593/000123580219000122/0001235802-19-000122-index.htm | ||
2019-10-15 | Sean E Browne | President and CEO | Buy | 329,044.00 | 329,044.00 | https://www.sec.gov/Archives/edgar/data/1453593/000123580219000129/0001235802-19-000129-index.htm | ||
2019-08-15 | GREG JENSEN | VP, Finance & CFO | Buy | 33,898.00 | 33,898.00 | https://www.sec.gov/Archives/edgar/data/1453593/000123580219000103/0001235802-19-000103-index.htm | ||
2018-08-15 | Kevin D Brandt | VP & Chief Commercial Officer | Buy | 40,000.00 | 40,000.00 | https://www.sec.gov/Archives/edgar/data/1453593/000123580218000122/0001235802-18-000122-index.htm | ||
2020-10-01 | Matthew Rizzo | Director | Buy | 46,784,775.00 | 1.07 | 50,059,709.25 | 52,702,384.00 | https://www.sec.gov/Archives/edgar/data/1453593/000123580220000118/0001235802-20-000118-index.htm |
2020-10-01 | Michael Eggenberg | Director | Buy | 46,784,775.00 | 1.07 | 50,059,709.25 | 52,702,384.00 | https://www.sec.gov/Archives/edgar/data/1453593/000123580220000119/0001235802-20-000119-index.htm |
2020-10-01 | ORBIMED ADVISORS LLC | Director | Buy | 46,784,775.00 | 1.07 | 50,059,709.25 | 52,702,384.00 | https://www.sec.gov/Archives/edgar/data/1453593/000123580220000117/0001235802-20-000117-index.htm |
2019-08-15 | Kevin D Brandt | Chief Commercial Officer | Buy | 35,169.00 | 75,169.00 | https://www.sec.gov/Archives/edgar/data/1453593/000123580219000104/0001235802-19-000104-index.htm | ||
2020-02-05 | Matthew Rizzo | Director | Buy | 70,423.00 | 91,256.00 | https://www.sec.gov/Archives/edgar/data/1453593/000123580220000006/0001235802-20-000006-index.htm | ||
2020-02-05 | Michael Eggenberg | Director | Buy | 70,423.00 | 91,256.00 | https://www.sec.gov/Archives/edgar/data/1453593/000123580220000007/0001235802-20-000007-index.htm |